APA
AVDL

American Portfolios Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

American Portfolios Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.5K Hold
500
– – ﹤0.01% 3055
2022
Q2 		$1.22K Buy
+500
New +$2.05K ﹤0.01% 3238
2018
Q3 		– Sell
-500
Closed -$3.06K – 2414
2018
Q2 		$3.06K Buy
+500
New +$3.51K ﹤0.01% 2115

Other funds holding AVDL

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

American Portfolios Advisors's AVDL Position: Q3 2022 in Review

American Portfolios Advisors held its Avadel Pharmaceuticals (AVDL) position steady in Q3 2022 at 500 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

American Portfolios Advisors first reported a position in AVDL in Q2 2018 and has held it in 3 quarters since. The position peaked at $3.06K in Q2 2018. 76 funds tracked by Wall St. Rank hold AVDL as of Q3 2022.

  • American Portfolios Advisors held 500 shares of Avadel Pharmaceuticals worth $2.5K as of Q3 2022.
  • American Portfolios Advisors left its Avadel Pharmaceuticals share count unchanged in Q3 2022.
  • Avadel Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3055 holding.
  • American Portfolios Advisors first reported a position in Avadel Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • American Portfolios Advisors's Avadel Pharmaceuticals position peaked at $3.06K in Q2 2018.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.